Chlorhexidine mouthwash reduces the salivary viral load of SARS‐CoV‐2: A randomized clinical trial
Denis Damião Costa, Carlos Brites, Sara Nunes Vaz, Daniele Souza De Santana, Jean Nunes Dos Santos, Patricia Ramos Cury
Oral Diseases, doi:10.1111/odi.14086
Objectives: This study aimed to evaluate the effect of 0.12% chlorhexidine gluconate on the salivary load of SARS-CoV-2.
Materials and Methods: A randomized, double-blind, placebo-controlled trial was performed on 100 participants positive for SARS-CoV-2. In the test group (n = 50), volunteers gargled with a mouthwash containing 15 ml of 0.12% chlorhexidine gluconate for 1 min, while the control group (n = 50) used a placebo. Saliva samples were obtained before (baseline) and 5 and 60 min after using the solutions. Real-time reverse transcription polymerase chain reaction assays (qRT-PCR) were carried out and the cycle threshold (Ct) was computed. The chi-square test and t-test were used for group comparison (p ≤ 0.05).
Results: The differences in Ct values between the 5-min evaluation and baseline (test group: 2.19 ± 4.30; control: -0.40 ± 3.87, p = 0.002) and between 60 min and baseline (test group: 2.45 ± 3.88; control: 0.76 ± 4.41, p = 0.05) were significantly greater in the test group, revealing a reduction of viral load. Furthermore, there was a reduction in the load of SARS-CoV-2 in 72% of the volunteers using chlorhexidine versus 30% in the control group (p = 0.001). Conclusions: Chlorhexidine gluconate (0.12%) was effective in reducing salivary SARS-CoV-2 load for at least 60 min.
TA B L E 4 Association between SARS-CoV-2 salivary viral load reduction from baseline and demographic data, cigarette smoking, health status and COVID-19 symptoms (N = 100)
PATI E NT CO N S E NT S TATE M E NT Participants signed the consent form.
PE R M I SS I O N TO R E PRO D U CE M ATE R I A L FRO M OTH E R S O U RCE S There is no material from other sources.
CLI N I C A L TR I A L R EG I S TR ATI O N It was registered on clinicaltrial.gov.br on 03/17/2021, protocol UTN U1111-1264-8920.
PE E R R E V I E W The peer review history for this article is available at https://publo ns.com/publo n/10.1111/odi.14086.
References
Bidra, Pelletier, Westover, Frank, Brown et al., Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses, Journal of Prosthodontics: Official Journal of the American College of Prosthodontists,
doi:10.1111/jopr.13220Blumenthal, Causino, Chang, Culpepper, Marder et al., The duration of ambulatory visits to physicians, The Journal of Family Practice
Burton, Clarkson, Goulao, Glenny, Mcbain et al., Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them,
doi:10.1002/14651858.CD013627.pub2Davies, Buczkowski, Welch, Green, Mawer et al., Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes, The Journal of General Virology,
doi:10.1099/jgv.0.001578Fe R E N C E S Addy, Jenkins, Newcombe, The effect of some chlorhexidine-containing mouthrinses on salivary bacterial counts, Journal of Clinical Periodontology,
doi:10.1111/j.1600-051x.1991.tb01694.xGanzeboom, Schröder, The international standard classification of education 2011
Geneva, Cuzzo, Fazili, Javaid, Normal body temperature: A systematic review, Open Forum Infectious Diseases,
doi:10.1093/ofid/ofz032Gorbalenya, Baker, Baric, Groot, Drosten et al., Coronaviridae study group of the international committee on taxonomy of viruses, the species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat Microbiol,
doi:10.1038/s41564-020-0695-zJain, Grover, Singh, Sharma, Das et al., Chlorhexidine: An effective anticovid mouth rinse, Journal of Indian Society of Periodontology,
doi:10.4103/jisp.jisp_824_20Koletsi, Belibasakis, Eliades, Interventions to reduce aerosolized microbes in dental practice: A systematic review with network meta-analysis of randomized controlled trials, Journal of Dental Research,
doi:10.1177/0022034520943574Komine, Yamaguchi, Okamoto, Yamamoto, Virucidal activity of oral care products against SARS-CoV-2 in vitro, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology,
doi:10.1016/j.ajoms.2021.02.002Letko, Marzi, Munster, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nature Microbiology,
doi:10.1038/s41564-020-0688-yMagleby, Westblade, Trzebucki, Simon, Rajan et al., Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America,
doi:10.1093/cid/ciaa851Nunes, None
Nunes, None
O'donnell, Thomas, Stanton, Maillard, Murphy et al., Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection, Function,
doi:10.1093/function/zqaa002Peng, Xu, Li, Cheng, Zhou et al., PubChem Compound Summary for CID 9552081, Chlorhexidine gluconate, International Journal of Oral Science,
doi:10.1038/s41368-020-0075-9Ramos, None
Seneviratne, Balan, Ko, Udawatte, Lai et al., Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized control trial in Singapore, Infection,
doi:10.1007/s15010-020-01563-9Shah, Singhal, Davar, Thakkar, No correlation between Ct values and severity of disease or mortality in patients with COVID 19 disease, Indian Journal of Medical Microbiology,
doi:10.1016/j.ijmmb.2020.10.021Souza De Santana, None
Stanley, Number of patients and patient visits; usual length of patient appointment. Bureau of economic research and statistics, Journal of the American Dental Association,
doi:10.1161/CIRCULATIONAHA.105.594945To, Tsang, Yip, Chan, Wu et al., Consistent detection of 2019 novel coronavirus in saliva, Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America,
doi:10.1093/cid/ciaa149Vaz, Santana, Netto, Pedroso, Wang et al., Saliva is a reliable, non-invasive specimen for SARS-CoV-2 detection, The Brazilian Journal of Infectious Diseases: an Official Publication of the Brazilian Society of Infectious Diseases,
doi:10.1016/j.bjid.2020.08.001Xu, Wang, Hoskin, Cugini, Markowitz et al., Differential effects of antiseptic mouth rinses on SARS-CoV-2 Infectivity in vitro, Pathogens,
doi:10.3390/pathogens10030272Yoon, Yoon, Song, Yoon, Lim et al., Clinical significance of a high SARS-CoV-2 viral load in the saliva, Journal of Korean Medical Science,
doi:10.3346/jkms.2020.35.e195DOI record:
{
"DOI": "10.1111/odi.14086",
"ISSN": [
"1354-523X",
"1601-0825"
],
"URL": "http://dx.doi.org/10.1111/odi.14086",
"abstract": "<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>This study aimed to evaluate the effect of 0.12% chlorhexidine gluconate on the salivary load of SARS‐CoV‐2.</jats:p></jats:sec><jats:sec><jats:title>Materials and Methods</jats:title><jats:p>A randomized, double‐blind, placebo‐controlled trial was performed on 100 participants positive for SARS‐CoV‐2. In the test group <jats:italic>(n</jats:italic> = 50), volunteers gargled with a mouthwash containing 15 ml of 0.12% chlorhexidine gluconate for 1 min, while the control group (<jats:italic>n</jats:italic> = 50) used a placebo. Saliva samples were obtained before (baseline) and 5 and 60 min after using the solutions. Real‐time reverse transcription polymerase chain reaction assays (qRT‐PCR) were carried out and the cycle threshold (Ct) was computed. The chi‐square test and <jats:italic>t</jats:italic>‐test were used for group comparison (<jats:italic>p </jats:italic>≤ 0.05).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The differences in Ct values between the 5‐min evaluation and baseline (test group: 2.19 ± 4.30; control: −0.40 ± 3.87, <jats:italic>p </jats:italic>= 0.002) and between 60 min and baseline (test group: 2.45 ± 3.88; control: 0.76 ± 4.41, <jats:italic>p </jats:italic>= 0.05) were significantly greater in the test group, revealing a reduction of viral load. Furthermore, there was a reduction in the load of SARS‐CoV‐2 in 72% of the volunteers using chlorhexidine versus 30% in the control group (<jats:italic>p </jats:italic>= 0.001).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Chlorhexidine gluconate (0.12%) was effective in reducing salivary SARS‐CoV‐2 load for at least 60 min.</jats:p></jats:sec>",
"alternative-id": [
"10.1111/odi.14086"
],
"assertion": [
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"order": 0,
"value": "2021-08-20"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"order": 1,
"value": "2021-11-09"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Published",
"name": "published",
"order": 2,
"value": "2021-12-11"
}
],
"author": [
{
"ORCID": "http://orcid.org/0000-0003-1702-5573",
"affiliation": [
{
"name": "Postgraduate Program in Dentistry and Health Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "Costa",
"given": "Denis Damião",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-4673-6991",
"affiliation": [
{
"name": "Infectious Diseases Research Laboratory Professor Edgard Santos Hospital Federal University of Bahia Salvador Brazil"
},
{
"name": "Postgraduate Program in Medicine and Health Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "Brites",
"given": "Carlos",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-7556-9670",
"affiliation": [
{
"name": "Postgraduate Program in Medicine and Health Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "Vaz",
"given": "Sara Nunes",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-0829-6817",
"affiliation": [
{
"name": "Postgraduate Program in Medicine and Health Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "de Santana",
"given": "Daniele Souza",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-7225-5879",
"affiliation": [
{
"name": "Postgraduate Program in Dentistry and Health Federal University of Bahia Salvador Brazil"
},
{
"name": "Department of Oral Pathology School of Dentistry Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "dos Santos",
"given": "Jean Nunes",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-8907-0483",
"affiliation": [
{
"name": "Postgraduate Program in Dentistry and Health Federal University of Bahia Salvador Brazil"
},
{
"name": "Department of Periodontology School of Dentistry Federal University of Bahia Salvador Brazil"
}
],
"authenticated-orcid": false,
"family": "Cury",
"given": "Patricia Ramos",
"sequence": "additional"
}
],
"container-title": "Oral Diseases",
"container-title-short": "Oral Diseases",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"onlinelibrary.wiley.com"
]
},
"created": {
"date-parts": [
[
2021,
11,
27
]
],
"date-time": "2021-11-27T04:20:30Z",
"timestamp": 1637986830000
},
"deposited": {
"date-parts": [
[
2023,
8,
22
]
],
"date-time": "2023-08-22T02:05:12Z",
"timestamp": 1692669912000
},
"funder": [
{
"DOI": "10.13039/501100006181",
"award": [
"0009/2014"
],
"doi-asserted-by": "publisher",
"name": "Fundação de Amparo à Pesquisa do Estado da Bahia"
},
{
"DOI": "10.13039/501100003593",
"award": [
"303861/2018‐5",
"407711/2018‐0"
],
"doi-asserted-by": "publisher",
"name": "Conselho Nacional de Desenvolvimento Científico e Tecnológico"
}
],
"indexed": {
"date-parts": [
[
2024,
3,
12
]
],
"date-time": "2024-03-12T01:59:14Z",
"timestamp": 1710208754851
},
"is-referenced-by-count": 23,
"issue": "S2",
"issued": {
"date-parts": [
[
2021,
12,
11
]
]
},
"journal-issue": {
"issue": "S2",
"published-print": {
"date-parts": [
[
2022,
11
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
12,
11
]
],
"date-time": "2021-12-11T00:00:00Z",
"timestamp": 1639180800000
}
}
],
"link": [
{
"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.14086",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1111/odi.14086",
"content-type": "application/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.14086",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "311",
"original-title": [],
"page": "2500-2508",
"prefix": "10.1111",
"published": {
"date-parts": [
[
2021,
12,
11
]
]
},
"published-online": {
"date-parts": [
[
2021,
12,
11
]
]
},
"published-print": {
"date-parts": [
[
2022,
11
]
]
},
"publisher": "Wiley",
"reference": [
{
"DOI": "10.1111/j.1600‐051x.1991.tb01694.x",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_2_1"
},
{
"DOI": "10.1111/jopr.13220",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_3_1"
},
{
"article-title": "The duration of ambulatory visits to physicians",
"author": "Blumenthal D.",
"first-page": "264",
"issue": "4",
"journal-title": "The Journal of Family Practice",
"key": "e_1_2_12_4_1",
"volume": "48",
"year": "1999"
},
{
"DOI": "10.1002/14651858.CD013627.pub2",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_5_1"
},
{
"key": "#cr-split#-e_1_2_12_6_1.1",
"unstructured": "Centers for Disease Control and Prevention - CDC. (2020).Guidance for dental settings: interim infection prevention and control guidance for dental settings during the coronavirus disease 2019 (COVID‐19) pandemic"
},
{
"key": "#cr-split#-e_1_2_12_6_1.2",
"unstructured": "[Accessed 2021 Jan 02]. Available from:https://www.cdc.gov/coronavirus/2019‐ncov/hcp/dental‐settings.html"
},
{
"key": "#cr-split#-e_1_2_12_7_1.1",
"unstructured": "Centers of Disease Control and Prevention - CDC. (2020).CDC 2019‐Novel Coronavirus (2019‐nCoV) Real‐Time RT‐PCR Diagnostic Panel"
},
{
"key": "#cr-split#-e_1_2_12_7_1.2",
"unstructured": "[Accessed 2021 Jan 05]. Available from:https://www.fda.gov/media/134922/download"
},
{
"DOI": "10.1099/jgv.0.001578",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_8_1"
},
{
"key": "e_1_2_12_9_1",
"unstructured": "Ganzeboom H. B. G. &Schröder H.(2015).The international standard classification of education 2011 [ISCED–2011]. In: Nederland in context: verschillen en overeenkomsten. Proceedings vijfde Nederlandse Workshop European Social Survey 11–34. [Accessed 2021 Jan 10]."
},
{
"DOI": "10.1093/ofid/ofz032",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_10_1"
},
{
"DOI": "10.1038/s41564‐020‐0695‐z",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_11_1"
},
{
"DOI": "10.4103/jisp.jisp_824_20",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_12_1"
},
{
"DOI": "10.1016/S1473‐3099(20)30237‐1",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_13_1"
},
{
"DOI": "10.1177/0022034520943574",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_14_1"
},
{
"DOI": "10.1016/j.ajoms.2021.02.002",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_15_1"
},
{
"DOI": "10.1038/s41564‐020‐0688‐y",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_16_1"
},
{
"DOI": "10.1093/cid/ciaa851",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_17_1"
},
{
"DOI": "10.1093/function/zqaa002",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_18_1"
},
{
"DOI": "10.1038/s41368‐020‐0075‐9",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_19_1"
},
{
"key": "#cr-split#-e_1_2_12_20_1.1",
"unstructured": "PubChem.(2004).Bethesda (MD): National Library of Medicine (US) National Center for Biotechnology Information"
},
{
"key": "#cr-split#-e_1_2_12_20_1.2",
"unstructured": "[Accessed 2021 June 13]. Available from:https://pubchem.ncbi.nlm.nih.gov/compound/Chlorhexidine‐gluconate"
},
{
"key": "#cr-split#-e_1_2_12_20_1.3",
"unstructured": "PubChem.(2004).Bethesda (MD): National Library of Medicine"
},
{
"key": "#cr-split#-e_1_2_12_20_1.4",
"unstructured": "(US) National Center for Biotechnology Information; PubChem Compound Summary for CID 9552081 Chlorhexidine gluconate; [Accessed 2021 June 13]. Available from:https://pubchem.ncbi.nlm.nih.gov/compound/Chlorhexidine‐gluconate"
},
{
"DOI": "10.1007/s15010‐020‐01563‐9",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_21_1"
},
{
"DOI": "10.1016/j.ijmmb.2020.10.021",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_22_1"
},
{
"DOI": "10.1161/CIRCULATIONAHA.105.594945",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_23_1"
},
{
"article-title": "Number of patients and patient visits; usual length of patient appointment. Bureau of economic research and statistics",
"author": "Survey of dental practice",
"first-page": "154",
"issue": "1",
"journal-title": "Journal of the American Dental Association (1939)",
"key": "e_1_2_12_24_1",
"volume": "85",
"year": "1972"
},
{
"DOI": "10.1093/cid/ciaa149",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_25_1"
},
{
"DOI": "10.1016/j.bjid.2020.08.001",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_26_1"
},
{
"DOI": "10.3390/pathogens10030272",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_27_1"
},
{
"DOI": "10.3346/jkms.2020.35.e195",
"doi-asserted-by": "publisher",
"key": "e_1_2_12_28_1"
}
],
"reference-count": 32,
"references-count": 32,
"relation": {
"has-review": [
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v1/decision1",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v2/review2",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v2/decision1",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v2/response1",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v1/review1",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v1/review2",
"id-type": "doi"
},
{
"asserted-by": "object",
"id": "10.1111/ODI.14086/v2/review1",
"id-type": "doi"
}
]
},
"resource": {
"primary": {
"URL": "https://onlinelibrary.wiley.com/doi/10.1111/odi.14086"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"General Dentistry",
"Otorhinolaryngology"
],
"subtitle": [],
"title": "Chlorhexidine mouthwash reduces the salivary viral load of SARS‐CoV‐2: A randomized clinical trial",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1002/crossmark_policy",
"volume": "28"
}
